Review of the pharmacokinetics of cefepime in children

Pediatric Infectious Disease Journal

Volumn 20, Issue 3, 2001, Pages 337-342

  Blumer, Jeffrey L ^a,b   Reed, Michael D ^b   Knupp, Catherine ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Bioavailability; Cefepime; Clearance; Half life; Linear; Meningitis; Pediatrics; Pharmacokinetics; Single dose; Steady state; Volume of distribution

Indexed keywords

CEFEPIME;

ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; DOSE CALCULATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG EFFICACY; DRUG EXCRETION; DRUG SAFETY; HUMAN; PEDIATRICS; PRIORITY JOURNAL; REVIEW; STEADY STATE;

ADOLESCENT; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; MENINGITIS, BACTERIAL; SAFETY; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035079385     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200103000-00032     Document Type: Review

References (17)

1. Carbapenems in paediatrics
2. Pediatric clinical pharmacology: A practical review
3. Safety, tolerance, and pharmacokinetics of cefepime administered intramuscularly to healthy subjects
4. Cefepime: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
5. Cefepime clinical pharmacokinetics
6. Cefepime: A fourth-generation parenteral cephalosporin
7. Cefepime vs. ceftazidime treatment of pyelonephritis: A European, randomized, controlled study of 300 pediatric cases
8. Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children
9. Cefepime versus ceftazidime in the empiric treatment of febrile neutropenic children with malignancy
10. Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children
11. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time
12. Estimation of mean residence time from data obtained when multiple-dosing steady state has been reached
13. Effects of age and gender on pharmacokinetics of cefepime
14. Principles of drug biodisposition in the neonate: A critical evaluation of the pharmacokinetic-pharmacodynamic interface (part II)
15. Effect of gestational age and birth weight on tobramycin kinetics in newborn infants